Advanced Therapy Medicinal Products, or ATMPs, are advanced therapeutic drugs that are based on cell therapy or gene therapy (sometimes in combination with a medical device - where they are then called a tissue engineered product).
The criteria to which a drug must conform to be classified as an ATMP, are defined in Article 17 of Regulation (EC) No 1394/2007 by the European Commission.
[1]
This pharmacology-related article is a stub.
You can help Wikipedia by expanding it.